The Arctic mutation accelerates Aβ aggregation in SDS through reducing the helical propensity of residues 15–25

References

• Glenner GG, Wong CW. Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984;120:885–90
   PubMed Web of Science ®Google Scholar
• Goldgaber D, Lerman MI, McBride OW, Saffiotti U, Gajdusek DC. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer’s disease. Science 1987;235:877–80
   PubMed Web of Science ®Google Scholar
• Tanzi RE, Gusella JF, Watkins PC, Bruns GA, St George-Hyslop P, Van Keuren ML, Patterson D, et al. Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 1987;235:880–4
   PubMed Web of Science ®Google Scholar
• Hardy JA, Higgins GA. Alzheimer’s disease: the amyloid cascade hypothesis. Science 1992;256:184–5
   PubMed Web of Science ®Google Scholar
• Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 2002;297:353–6
   PubMed Web of Science ®Google Scholar
• Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, Lannfelt L. A pathogenic mutation for probable Alzheimer’s disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1992;1:345–7
   PubMed Web of Science ®Google Scholar
• Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 1991;349:704–6
   PubMed Web of Science ®Google Scholar
• Murrell J, Farlow M, Ghetti B, Benson MD. A mutation in the amyloid precursor protein associated with hereditary Alzheimer’s disease. Science 1991;254:97–9
   PubMed Web of Science ®Google Scholar
• Chartier-Harlin MC, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, Goate A, et al. Early-onset Alzheimer’s disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature 1991;353:844–6
   PubMed Web of Science ®Google Scholar
• Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C, Stenh C, et al. The ‘Arctic’ APP mutation (E693G) causes Alzheimer’s disease by enhanced Abeta protofibril formation. Nat Neurosci 2001;4:887–93
   PubMed Web of Science ®Google Scholar
• Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, van Duinen SG, Bots GT, et al. Mutation of the Alzheimer’s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990;248:1124–6
   PubMed Web of Science ®Google Scholar
• Hendriks L, van Duijn CM, Cras P, Cruts M, Van Hul W, van Harskamp F, Warren A, et al. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet 1992;1:218–21
   PubMed Web of Science ®Google Scholar
• Grabowski TJ, Cho HS, Vonsattel JP, Rebeck GW, Greenberg SM. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 2001;49:697–705
   PubMed Web of Science ®Google Scholar
• Bugiani O, Giaccone G, Rossi G, Mangieri M, Capobianco R, Morbin M, Mazzoleni G, et al. Hereditary cerebral hemorrhage with amyloidosis associated with the E693K mutation of APP. Arch Neurol 2010;67:987–95
   PubMedGoogle Scholar
• Hori Y, Hashimoto T, Wakutani Y, Urakami K, Nakashima K, Condron MM, Tsubuki S, et al. The Tottori (D7N) and English (H6R) familial Alzheimer disease mutations accelerate Abeta fibril formation without increasing protofibril formation. J Biol Chem 2007;282:4916–23
   PubMedGoogle Scholar
• Morimoto A, Irie K, Murakami K, Ohigashi H, Shindo M, Nagao M, Shimizu T, et al. Aggregation and neurotoxicity of mutant amyloid beta (A beta) peptides with proline replacement: importance of turn formation at positions 22 and 23. Biochem Biophys Res Commun 2002;295:306–11
   PubMed Web of Science ®Google Scholar
• Murakami K, Irie K, Morimoto A, Ohigashi H, Shindo M, Nagao M, Shimizu T, et al. Synthesis, aggregation, neurotoxicity, and secondary structure of various A beta 1–42 mutants of familial Alzheimer’s disease at positions 21–23. Biochem Biophys Res Commun 2002;294:5–10
   PubMed Web of Science ®Google Scholar
• Haass C, Steiner H. Protofibrils, the unifying toxic molecule of neurodegenerative disorders? Nat Neurosci 2001;4:859–60
   PubMed Web of Science ®Google Scholar
• Jarrett JT, Lansbury PT Jr. Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer’s disease and scrapie? Cell 1993;73:1055–8
   PubMed Web of Science ®Google Scholar
• Lomakin A, Chung DS, Benedek GB, Kirschner DA, Teplow DB. On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. Proc Natl Acad Sci USA 1996;93:1125–9
   PubMed Web of Science ®Google Scholar
• Soto C, Castano EM, Frangione B, Inestrosa NC. The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation. J Biol Chem 1995;270:3063–7
   PubMed Web of Science ®Google Scholar
• Miravalle L, Tokuda T, Chiarle R, Giaccone G, Bugiani O, Tagliavini F, Frangione B, et al. Substitutions at codon 22 of Alzheimer’s abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. J Biol Chem 2000;275:27110–16
   PubMed Web of Science ®Google Scholar
• Rodziewicz-Motowidlo S, Juszczyk P, Kolodziejczyk AS, Sikorska E, Skwierawska A, Oleszczuk M, Grzonka Z. Conformational solution studies of the SDS micelle-bound 11–28 fragment of two Alzheimer’s beta-amyloid variants (E22K and A21G) using CD, NMR, and MD techniques. Biopolymers 2007;87:23–39
   PubMedGoogle Scholar
• Rodziewicz-Motowidlo S, Czaplewska P, Sikorska E, Spodzieja M, Kolodziejczyk AS. The Arctic mutation alters helix length and type in the 11–28 beta-amyloid peptide monomer-CD, NMR and MD studies in an SDS micelle. J Struct Biol 2008;164:199–209
   PubMedGoogle Scholar
• Lee EK, Hwang JH, Shin DY, Kim DI, Yoo YJ. Production of recombinant amyloid-beta peptide 42 as an ubiquitin extension. Protein Expr Purif 2005;40:183–9
   PubMed Web of Science ®Google Scholar
• Wishart DS, Bigam CG, Yao J, Abildgaard F, Dyson HJ, Oldfield E, Markley JL, et al. 1H, 13C and 15N chemical shift referencing in biomolecular NMR. J Biomol NMR 1995;6:135–40
   PubMed Web of Science ®Google Scholar
• Lobley A, Whitmore L, Wallace BA. DICHROWEB: an interactive website for the analysis of protein secondary structure from circular dichroism spectra. Bioinformatics 2002;18:211–12
   PubMed Web of Science ®Google Scholar
• Whitmore L, Wallace BA. DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res 2004;32:W668–73
   PubMed Web of Science ®Google Scholar
• Whitmore L, Wallace BA. Protein secondary structure analyses from circular dichroism spectroscopy: methods and reference databases. Biopolymers 2008;89:392–400
   PubMed Web of Science ®Google Scholar
• Weinstock DS, Narayanan C, Baum J, Levy RM. Correlation between 13Calpha chemical shifts and helix content of peptide ensembles. Protein Sci 2008;17:950–4
   PubMedGoogle Scholar
• Wishart DS, Sykes BD. The 13C chemical-shift index: a simple method for the identification of protein secondary structure using 13C chemical-shift data. J Biomol NMR 1994;4:171–80
   PubMed Web of Science ®Google Scholar
• Wishart DS, Sykes BD. Chemical shifts as a tool for structure determination. Methods Enzymol 1994;239:363–92
   PubMed Web of Science ®Google Scholar
• Berjanskii MV, Wishart DS. A simple method to predict protein flexibility using secondary chemical shifts. J Am Chem Soc 2005;127:14970–1
   PubMed Web of Science ®Google Scholar
• Berjanskii MV, Wishart DS. The RCI server: rapid and accurate calculation of protein flexibility using chemical shifts. Nucleic Acids Res 2007;35:W531–7
   PubMedGoogle Scholar
• Chen YR, Huang HB, Lo CJ, Wang CC, Su CL, Liu HT, Shiao MS, et al. Abeta40(L17A/F19A) mutant diminishes the aggregation and neurotoxicity of Abeta40. Biochem Biophys Res Commun 2011;405:91–5
   PubMed Web of Science ®Google Scholar
• Barrett PJ, Song Y, Van Horn WD, Hustedt EJ, Schafer JM, Hadziselimovic A, Beel AJ, et al. The amyloid precursor protein has a flexible transmembrane domain and binds cholesterol. Science 2012;336:1168–71
   PubMed Web of Science ®Google Scholar
• Song Y, Mittendorf KF, Lu Z, Sanders CR. Impact of bilayer lipid composition on the structure and topology of the transmembrane amyloid precursor c99 protein. J Am Chem Soc 2014;136:4093–6
   PubMedGoogle Scholar
• Jarvet J, Danielsson J, Damberg P, Oleszczuk M, Graslund A. Positioning of the Alzheimer Abeta(1–40) peptide in SDS micelles using NMR and paramagnetic probes. J Biomol NMR 2007;39:63–72
   PubMedGoogle Scholar
• Kallberg Y, Gustafsson M, Persson B, Thyberg J, Johansson J. Prediction of amyloid fibril-forming proteins. J Biol Chem 2001;276:12945–50
   PubMed Web of Science ®Google Scholar
• Chen YR, Huang HB, Lo CJ, Wang CC, Ho LK, Liu HT, Shiao MS, et al. Effect of alanine replacement of l17 and f19 on the aggregation and neurotoxicity of arctic-type abeta40. PLoS One 2013;8:e61874
   PubMedGoogle Scholar
• Paivio A, Nordling E, Kallberg Y, Thyberg J, Johansson J. Stabilization of discordant helices in amyloid fibril-forming proteins. Protein Sci 2004;13:1251–9
   PubMed Web of Science ®Google Scholar
• Norlin N, Hellberg M, Filippov A, Sousa AA, Grobner G, Leapman RD, Almqvist N, et al. Aggregation and fibril morphology of the Arctic mutation of Alzheimer’s Abeta peptide by CD, TEM, STEM and in situ AFM. J Struct Biol 2012;180:174–89
   PubMed Web of Science ®Google Scholar
• Harper JD, Wong SS, Lieber CM, Lansbury PT. Observation of metastable Abeta amyloid protofibrils by atomic force microscopy. Chem Biol 1997;4:119–25
   PubMed Web of Science ®Google Scholar
• Bokvist M, Lindstrom F, Watts A, Grobner G. Two types of Alzheimer’s beta-amyloid (1–40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation. J Mol Biol 2004;335:1039–49
   PubMed Web of Science ®Google Scholar
• Sabate R, Espargaro A, Barbosa-Barros L, Ventura S, Estelrich J. Effect of the surface charge of artificial model membranes on the aggregation of amyloid beta-peptide. Biochimie 2012;94:1730–8
   PubMedGoogle Scholar